(Q41774667)

9 October 2017

In vitro induction of regulatory T cells by anti-CD3 antibody in humans (English)

1 reference

9 October 2017

7

Howard L Weiner

1 reference

9 October 2017

Michal Abraham

1

1 reference

9 October 2017

Arnon Karni

2

1 reference

9 October 2017

Adi Dembinsky

3

1 reference

9 October 2017

Ariel Miller

4

1 reference

9 October 2017

Roopali Gandhi

5

1 reference

9 October 2017

David Anderson

6

1 reference

9 October 2017

1 February 2008

1 reference

9 October 2017

Journal of Autoimmunity

1 reference

9 October 2017

30

1 reference

9 October 2017

1-2

1 reference

9 October 2017

21-28

1 reference

Cell damage and autoimmunity: a critical appraisal

9 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Pathogenesis of PR3-ANCA associated vasculitis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Epigenetic clues to rheumatoid arthritis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

FoxP3: a genetic link between immunodeficiency and autoimmune diseases

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

IPEX and FOXP3: clinical and research perspectives

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

CD4+ regulatory T cells: mechanisms of induction and effector function.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Use of reduced dose of OKT3 (2.5 mg) after renal transplantation

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239265

Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolysis

3 November 2018

1 reference

12 December 2020

Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?

1 reference

12 December 2020

Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

Immunotherapy of insulin-dependent diabetes mellitus

1 reference

12 December 2020

Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3

1 reference

12 December 2020

Integrating immunity: the immunculus and self-reactivity

1 reference

12 December 2020

Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action

1 reference

12 December 2020

The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients

1 reference

12 December 2020

OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient

1 reference

12 December 2020

A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter study

1 reference

12 December 2020

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4

1 reference

12 December 2020

Anergic T cells inhibit the antigen-presenting function of dendritic cells

1 reference

12 December 2020

10.1016/J.JAUT.2007.11.007

Identifiers

DOI

1 reference

9 October 2017

1 reference

9 October 2017

PubMed publication ID

18191540

1 reference